September 2026
The hemophilia market size reached USD 13.31 billion in 2026, with leading hemophilia market companies including Bayer, Novo Nordisk, Pfizer, Sanofi.
September 2026
The hemophilia treatment market was valued at USD 23.23 billion in 2026, with leading companies including Shire, CSL Behring, Grifols, S.A., Biogen Inc..